SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Vascular Biogenics Ltd. (VBLT)

VBLT RSS Feed
Add VBLT Price Alert      Hide Sticky   Hide Intro
Moderator: gr8db8
Search This Board: 
Last Post: 11/19/2017 5:22:25 PM - Followers: 44 - Board type: Free - Posts Today: 0

Vascular Biogenics Ltd is an Israel-based clinical-stage biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of treatments for cancer and immune-inflammatory diseases. Its clinical pipeline is based on two platform technologies that leverage the body’s natural physiologic and genetic regulatory elements. As of June 6, 2014, it has developed two programs based on these platforms an oncology program and an anti-inflammatory program. Its lead product candidate from its oncology program, VB-111, is a gene-based biologic that is initially developing for recurrent glioblastoma (rGBM), an aggressive form of brain cancer. The Company has also received orphan drug designation in both the United States and Europe. The Company’s oncology program is based on its Vascular Targeting System (VTS), platform technology, which utilizes genetically targeted therapy to destroy newly formed, or angiogenic, blood vessels. http://www.vblrx.com
SureTrader
Interactive Brokers Advertisement
VBLT
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
VBLT News: VBL Therapeutics Prices  2.5 Million Ordinary Share Offering 11/17/2017 09:00:00 AM
VBLT News: Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) 11/16/2017 05:15:46 PM
VBLT News: VBL Therapeutics Announces Proposed Public Offering of 2.5 Million Shares of Ordinary Shares 11/16/2017 04:01:00 PM
VBLT News: Report of Foreign Issuer (6-k) 11/14/2017 07:01:16 AM
VBLT News: VBL Therapeutics Announces Third Quarter 2017 Financial Results 11/14/2017 07:00:00 AM
PostSubject
#1655   Exactly! I think this has very little to wcopeland 11/19/17 05:22:25 PM
#1654   I would guess there has been partnership and gr8db8 11/19/17 04:12:05 PM
#1653   Yes, but if they are confident about their Jumpinjackas 11/19/17 10:14:36 AM
#1652   They do have great expectations for returned value avtrdr 11/18/17 05:30:18 PM
#1651   jumpinjackas, NanoCarrier has rights for all indications. So gr8db8 11/18/17 03:22:31 PM
#1650   Agree wcopeland. That's my read as well. For gr8db8 11/18/17 03:15:07 PM
#1649   I am also okay with the offering. avtrdr 11/18/17 02:46:13 PM
#1648   The ceo is super trusted. He played the Oren1976 11/18/17 01:32:23 PM
#1647   I support this dilution and the high price Oren1976 11/18/17 01:30:16 PM
#1646   The really question is: can we trust this staccani 11/18/17 01:27:23 PM
#1645   This offering was a bit of a gut wcopeland 11/18/17 12:52:22 PM
#1644   Also, remember someone just handed them 15 million Jumpinjackas 11/18/17 11:52:21 AM
#1643   I am no expert but I now think mantoo123 11/18/17 09:53:03 AM
#1642   Hey Guys, just relax when vblt issue any Valueinvestor12 11/18/17 09:30:55 AM
#1641   mantoo123, good post. I agree with your CHM_760 11/18/17 07:43:46 AM
#1640   Stock offering will raise additional $18.75 million extending mantoo123 11/17/17 06:44:56 PM
#1639   BIOMARKER ANALYSIS SUPPORTS THE VB-111 DUAL MECHANISM OF ACTION gr8db8 11/17/17 02:38:54 AM
#1638   BTW, on another point. At the last financing davidal66 11/16/17 06:51:21 PM
#1637   VBLT will be stronger financially after this dilution. Valueinvestor12 11/16/17 06:06:50 PM
#1636   Per SEC filing, this is part of the gr8db8 11/16/17 05:35:27 PM
#1635   VBL Therapeutics launches 2.5M-share offering kpisme 11/16/17 05:02:31 PM
#1634   U were right dilution Oren1976 11/16/17 04:17:36 PM
#1633   I prefer not to disclose but more than 20000 Oren1976 11/16/17 12:02:52 PM
#1632   Nice -- might bleed a bit before results, SCHB 11/16/17 11:48:50 AM
#1631   I bought today my last portion at price Oren1976 11/16/17 11:25:22 AM
#1630   I listened to that response too, and the SCHB 11/15/17 10:29:08 AM
#1629   looks like he simply meant to say mazlat10 11/15/17 04:05:12 AM
#1628   VBLT closed at 235m... mazlat10 11/15/17 03:59:46 AM
#1627   It's the first time he said that correct Oren1976 11/15/17 02:15:44 AM
#1626   Pay attention to the answer ' unexpected, happening" Valueinvestor12 11/15/17 01:12:58 AM
#1625   Haha, I can't speak to that. What would SCHB 11/14/17 11:23:20 PM
#1624   5B is ok with me but I don't Oren1976 11/14/17 10:58:29 PM
#1623   My mistake on the monotherapy part, Oren, thanks SCHB 11/14/17 10:46:43 PM
#1622   one more thing. things are different now, we Oren1976 11/14/17 10:25:38 PM
#1621   First VB-111 was tested as monotherapy with ph2 Oren1976 11/14/17 10:20:53 PM
#1620   We're at 200MM market cap now. Let's assume SCHB 11/14/17 08:03:29 PM
#1619   189 events already hit yes or no ? Oren1976 11/14/17 06:32:35 PM
#1618   Congrats to all the VBLT longs Are extraordinary mjw007 11/14/17 05:24:15 PM
#1617   TEL AVIV, Israel, Nov. 14, 2017 (GLOBE NEWSWIRE) CHM_760 11/14/17 07:19:52 AM
#1616   I thought the same thing... didn't Dror previously davidal66 11/13/17 11:53:15 PM
#1615   Is anyone optimistic that we could hear news tpizzazz24 11/13/17 08:41:54 PM
#1614   Off topping to wcopeland sorry to the board. Valueinvestor12 11/13/17 06:57:35 PM
#1613   Very good catch, as always! In hindsight, there wcopeland 11/13/17 11:13:52 AM
#1612   Nice catch -- sounds like a great strategic move. SCHB 11/12/17 09:51:17 PM
#1611   Looking back at Dror's comments in the last gr8db8 11/12/17 07:51:41 PM
#1610   Perhaps by "early" what they mean is that SCHB 11/11/17 02:03:45 PM
#1609   "VB-111 is expected to receive early approval." That's gr8db8 11/11/17 01:26:20 PM
#1608   Were there a lot of negative posts on SCHB 11/11/17 11:27:22 AM
#1607   I think there won't be financing in the Oren1976 11/11/17 08:38:13 AM
#1606   I told u back then it was a Oren1976 11/11/17 08:28:43 AM
PostSubject